(Research Triangle Park, N.C.) Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today that the Helmholtz Zentrum Muenchen, Research Center for Environmental Health (www.helmholtz-muenchen.de) in Neuherberg, Germany, has successfully completed Metabolon’s validation requirements. This collaboration brings Metabolon’s technology platform to Germany. (more…)

(Research Triangle Park, N.C.) Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announces the launch of its Disease Metabolism Strategic Outsourcing Program. (more…)

(Research Triangle Park, N.C.) Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announces the grant of US Patent 8,131,473 “Data Analysis Methods for Locating Entities of Interest within Large Multivariable Datasets.” The patent was issued on March 6, 2012 and is the sixth technology patent and nineteenth patent overall awarded to Metabolon. The invention describes analysis methods and computational tools developed by Metabolon to quickly and accurately locate biochemicals, genes and proteins of interest in large multivariate data. (more…)

(Research Triangle Park, N.C.) As part of an ongoing effort to build a stronger technology community in North Carolina, NCTechNews will be publishing Q&A profile sessions with select businesses and organizations throughout our state. In today’s installment, NCTechNews talks with Samir Dandekar, one of the co-founders of Apex-based Code Refinery, a software development firm specializing in the medical devices and diagnostics market sectors.

Q: When did Code Refinery launch and why?
A: Our company launched in 1997 to fill unmet needs in turnkey software development services specifically for lab automation and integration. (more…)

(Durham, N.C.) Top researchers and industry experts witnessed the first full-run demonstration of new technology that will help dairy producers improve profitability, milk quality and animal welfare through earlier, more accurate detection of mastitis. Advanced Animal Diagnostics (AAD), a developer of technologies for the diagnosis of production animal diseases, conducted a demonstration of its technology during the 51st Annual Meeting of the National Mastitis Council (NMC) in St. Pete Beach, Florida, on Jan. 23.  About 50 researchers, veterinarians, processors and dairy industry professionals representing eight countries attended the presentation. (more…)

(Raleigh, N.C.) LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) technology, today announced that Timothy J. Fischer has been named Chief Operating Officer. Mr. Fischer joined LipoScience in 2010 as Vice President of Research and Development. In his new role, Mr. Fischer will oversee research and development, commercial operations and medical affairs. (more…)

(Burlington, N.C.) Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that it has entered into a new senior unsecured credit facility totaling $1.0 billion. Bank of America, N.A. will act as Administrative Agent and Barclays Capital will serve as Syndication Agent for a group of financial institutions providing the facility. (more…)

(Research Triangle Park, N.C.) Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today the appointment of Eric Button as Senior Vice President of Diagnostics. In this position, Mr. Button will have responsibility for all aspects of Metabolon’s diagnostics operations, and will report to the company’s CEO John Ryals. (more…)

(Research Triangle Park, N.C.) Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today that they have received laboratory accreditation from the College of American Pathologists (CAP). (more…)

(Burlington, N.C.) Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on November 14, 2011 LabCorp’s previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH). On May 17, 2011, LabCorp received a request from the Federal Trade Commission, or the FTC, for additional information under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the acquisition of Orchid by LabCorp. LabCorp previously extended its tender offer to November 4, 2011. LabCorp is continuing to cooperate with the FTC’s request for additional information and is consequently further extending the expiration of the tender offer. (more…)

(Raleigh, N.C.) LipoScience, Inc., an in-vitro diagnostic company advancing patient care in cardiovascular, metabolic and other diseases using an innovative and proprietary platform based on Nuclear Magnetic Resonance (NMR) technology, today announced the appointment of Robert Honigberg, M.D. as Chief Medical Officer and Vice President, Medical Affairs. Dr. Honigberg’s responsibilities will include the development and implementation of strategies for clinical trials, partnerships, and publications for both marketed and pipeline products. In addition, he will lead the development of relationships with medical societies, advocacy organizations, academic institutions, health plans, and business partners as LipoScience continues to expand its geographic reach. (more…)

(Burlington, N.C.) Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on November 4, 2011 LabCorp’s previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH). On May 17, 2011, LabCorp received a request from the Federal Trade Commission, or the FTC, for additional information under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, applicable to the acquisition of Orchid by LabCorp. LabCorp previously extended its tender offer to October 7, 2011. LabCorp is continuing to cooperate with the FTC’s request for additional information and is consequently further extending the expiration of the tender offer. (more…)